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Summary prises a clinically and genetically heterogeneous group
of disorders sharing a defective mechanism of bone re-
Albers-Scho¨nberg disease, the classical form of os- sorption, which results in an increased bone density
teopetrosis, is an autosomal dominant condition with (Beighton and Horan 1977). The terminology of the
generalized increased skeletal density due to reduced different types of osteopetrosis, however, is confusing
bone resorption. Characteristic radiological ﬁndings are (table 1). In general, osteopetrosis is divided into three
generalized osteosclerosis, with, most typically, end- forms (Shapiro 1993). One form (MIM 259700) is a
plate sandwichlike thickening of the vertebrae (Rugger- malignant osteopetrosis with a recessive mode of inheri-
Jersey spine) and the bone-within-bone (endobones) tance affecting children from the neonatal period on.
phenomenon. We studied an extended kindred with Al- The patients have different neurological symptoms
bers-Scho¨nberg disease and found linkage with several (blindness, deafness, and/or facial palsy), hematological
markers from chromosome 1p21. The Albers-Scho¨nberg abnormalities (anemia, thrombocytopenia, and/or leu-
gene is located in a candidate region of Ç8.5 cM ﬂanked copenia) and usually die of bleeding or infection within
by markers D1S486 and D1S2792. A maximum LOD the ﬁrst years of life (Loria-Corte´s et al. 1977; Gerritsen
score (Zmax) of 4.09 was obtained in multipoint analysis et al. 1994). A second form (MIM 166600), now re-
at loci D1S239/D1S248. Possible linkage of os- ferred to as ‘‘Albers-Scho¨nberg disease’’ or ‘‘marble
teopetrosis to this chromosomal region was analyzed bone disease,’’ is more benign and has an autosomal
because the CSF-1 gene, which is mutated in the op/ dominant form of inheritance (Johnston et al. 1968;
op mouse model for osteopetrosis, is located in 1p21. Bollerslev 1989). A third form (MIM 259710) is inter-
However, SSCP and mutation analysis in patients did mediate, with an autosomal recessive inheritance but a
not reveal any abnormality, which excludes the CSF-1 much milder course (Horton et al. 1980; Kahler et al.
gene as the disease-causing gene. This was conﬁrmed by 1984). A particular subtype (MIM 259730) of the latter
reﬁned physical mapping of the CSF-1 gene outside the type is associated with renal tubular acidosis and cere-
candidate region for the Albers-Scho¨nberg gene. The bral calciﬁcation (Whyte et al. 1980), because of a deﬁ-
identiﬁcation of the molecular defect underlying Albers- ciency of carbonic anhydrase II (Sly et al. 1983, 1985)
Scho¨nberg disease will therefore be dependent on the (table 1).
isolation of other genes from an 8.5-cM candidate re- Patients with the autosomal dominant form of os-
gion on chromosome 1p21. teopetrosis suffer from periodic back pain, bone pain,
headache, and recurrent fractures (table 1). Other symp-
toms may include osteomyelitis and compression of cra-Introduction
nial nerves, leading to deafness, loss of vision, and facial
In 1904 Albers-Scho¨nberg described a patient suffering nerve palsy. The frequency of this condition has been
from several fractures due to generalized sclerosis of the estimated at 1:100,000–1:500,000 (Johnston et al.
skeleton (Albers-Scho¨nberg 1904). Later on, the terms 1968), but an extended and detailed epidemiological
‘‘osteopetrosis’’ and ‘‘marble bone disease’’ were intro- study in Denmark revealed a frequencyú1:20,000 (Bol-
duced (Karschner 1926). At present, osteopetrosis com- lerslev 1987). The underestimation of the disease fre-
quency in the ﬁrst study can be explained partly by the
fact that approximately half of the cases are asymptom-
atic and are often detected only by incidental radiogra-Received March 13, 1997; accepted for publication May 20, 1997.
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Table 1
Different Types of Osteopetrosis
Type Inheritance Typical Symptom(s) Primary Defect MIM Number
Malignant Recessive Neurological symptoms, bleeding, infection, Unknown 259700
early death
Benign:
Type I Dominant Cranial vault sclerosis Unknown 166600
Type II (Albers-Scho¨nberg) Dominant Rugger-jersey spine, endobones Unknown 166600
Intermediate Recessive Short stature, anemia, fractures Unknown 259710
Recessive Renal tubular acidosis, cerebral calciﬁcation Carbonic anhydrase II 259730
nial vault, whereas, in autosomal dominant os- 1970). For two of these models, the underlying mutation
has been identiﬁed: in the op/op mouse, a mutation hasteopetrosis type II (Albers-Scho¨nberg disease), only the
base of the skull is dense. Albers-Scho¨nberg disease is been found in the coding region of the macrophage-
colony-stimulating–factor gene (Csfm) (Yoshida et al.further characterized by the sandwichlike appearance of
the spine, which is due to end-plate thinkening of the 1990), whereas the mi/mi (microphthalmia) mouse is
associated with mutations in the microphthalmia genevertebrae (Rugger-Jersey spine), and by endobones
(‘‘bone within a bone’’) in the pelvis (ﬁg. 1). Albers- (Hodgkinson et al. 1993). Besides these naturally oc-
curring autosomal recessive animal mutants, it has beenScho¨nberg patients show increased serum values of acid
phosphatase, increased frequency of fractures, and, shown that disruption of the proto-oncogenes c-src and
c-fos in mice also results in osteopetrosis (Soriano et al.sometimes, nonpenetrance. None of the latter ﬁndings is
present in type I patients, and both types of osteopetrosis 1991; Wang et al. 1992). More recently, it has been
shown that the disruption of the Acp 5 gene (Haymanseem to breed in different families. This indicates that
the autosomal dominant form of osteopetrosis consists et al. 1996) and of the hematopoietic transcription fac-
tor PU.1 also results in osteopetrosis (Tondravi et al.of two different entities (Bollerslev and Andersen 1988).
The diversity of gene mutations leading to os- 1995). We now report the results of a linkage study in
an extended kindred with Albers-Scho¨nberg disease.teopetrosis is illustrated by the fact that §10 distinct
animal models have already been reported (Marks
1989), including four mouse mutants (gl/gl, mi/mi, oc/ Subjects and Methods
oc, and op/op) (Gru¨nberg 1935, 1948; Marks and Lane
1976; Marks et al. 1985), three rat mutants (ia/ia, op/ Ascertainment of the Family
op, and tl/tl) (Marks 1973, 1977, 1989), and undeﬁned Blood samples were taken from 31 family members
osteopetrosis in rabbit (Pearce and Brown 1948), cow from an extended Danish kindred with Albers-Scho¨n-
(Thomson 1966), and dog (Riser and Frankhauser berg disease, already described elsewhere (Bollerslev
1987). Patients were diagnosed on the basis of x-rays
taken from the skull and the thoracolumbal spine. In
comparison with the pedigree described in the original
study, two individuals (II-16 and III-26) have meanwhile
been diagnosed as affected. Genotyping of individuals
II-8, III-9, and III-12 showed three different paternal
haplotypes, indicating that at least one of them origi-
nates from a different biological father.
Genotyping
Genomic DNA was isolated from whole blood by
standard techniques. Microsatellite markers were typed
by radiolabeled PCR, with separation according to size,
Figure 1 Typical radiological features in Albers-Scho¨nberg dis- on polyacrylamide gels and were vizualized by autoradi-
ease. A, Lateral view of spine in a young man with Albers-Scho¨nberg ography. For linkage analysis with candidate genes, mi-
disease, showing the characteristic ‘‘Rugger-Jersey spine’’ with sand-
crosatellite markers used were selected on the basis ofwichlike vertebrae that are due to sclerosis of the end plates. B, Frontal
the available mapping of these genes.view of the pelvis in an Albers-Scho¨nberg patient, showing the ‘‘bone-
within-bone’’ appearance in the iliac wings. The human SRC gene was assigned by FISH to chro-
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mosome band 20q11.2 (Morris et al. 1989), and the (Ladner et al. 1987) were synthesized on the basis of
available intron sequences (M. Ladner, personal com-availability of an intragenic dinucleotide repeat (Xiang
et al. 1991) allowed detailed genetic mapping between munication). The results obtained on three patients (II-
10, II-11, and III-25) were compared with those on sev-D20S106 (proximal side) and D20S107 (distal side)
(Gyapay et al. 1994). The human FOS gene is located eral control samples. Finally, the exons and intron-exon
boundaries of the CSF-1 gene of patients II-9 and II-10within chromosomal region 14q21-q31 (Barker et al.
1984). No highly polymorphic marker is available were sequenced by direct sequencing of the PCR prod-
ucts, on an automatic sequencer, ABI-373, using dyewithin this gene, but physical mapping data indicate that
microsatellite markers D14S284 and D14S273 are on terminator-sequencing protocols.
opposite sites of the FOS gene, at a distance £100 kb
Screening of YACs(Cruts et al. 1995). This allowed us to use these two
markers to study linkage with the FOS gene. The MITF DNA from CEPH YACs was prepared by use of stan-
gene has been assigned by FISH to chromosome 3p14.1- dard protocols and was tested for the presence of loci,
p12.3 (Tichibana et al. 1994), but no intragenic poly- by standard PCR conditions.
morphisms in the MITF gene have been described. Mu-
tations in the MITF gene lead to Waardenburg syn- Results
drome type 2 (Tassabehji et al. 1994), and, since no
recombinations between this disease and D3S1261 have Since the gene implicated in Albers-Scho¨nberg disease
has not yet been mapped on the human genome, webeen reported (Hughes et al. 1994), D3S1261 was used
in our linkage analysis. The CSF-1 gene has been as- performed linkage analysis in a large Danish family with
this disease. The clinical, radiological, and biochemicalsigned by FISH to chromosome band 1p21 (Landegent
et al. 1992). No detailed genetic mapping information features of this family have been reported elsewhere
(Bollerslev 1987, 1995). We performed linkage analysisof the CSF-1 gene is currently available, since only one
RFLP with low information content has been reported in this family, with DNA markers in or around genes
mutated in animal models for osteopetrosis—includingfor this gene (Heinzmann et al. 1989). However, the
murine homologue, csfm, maps to chromosome 3 in the genes SRC, FOS, MITF, and CSF-1—even though these
are recessive mutants.mouse, close to the cluster of Amy genes (Gisselbrecht
et al. 1989). The Amy genes are part of a syntenic group In the initial phase of our linkage study, eight affected
family members were typed for markers in or close tothat is conserved between mouse chromosome 3 and
human chromosome 1 (Moseley and Seldin 1989). candidate genes. This excluded SRC and FOS as candi-
date genes (data not shown). However, no exclusionTherefore, a CA repeat in the AMY2B gene (Dracopoli
and Meisler (1990) was used to test linkage with the for MITF and CSF-1 could be obtained. Therefore, 23
additional family members were included in the linkageCSF-1 gene.
analysis (ﬁg. 2). One additional marker, D3S3551, lo-
Linkage Analysis cated 1.6 cM proximal of D3S1261, was also analyzed,
to study MITF as a candidate gene. However, pairwiseTwo-point LOD scores were calculated by use of
MLINK (version 5.1) in the FASTLINK implementation LOD scores for linkage with Albers-Scho¨nberg disease
were negative, both for D3S1261 and for D3S3551.(version 2.2) (Lathrop and Lalouel 1984). Multipoint
analysis was performed by use of the VITESSE algorithm Since multipoint analysis resulted in LOD scores õ02
for a chromosomal region ú20 cM around the MITF(O’Connell and Weeks 1995). The disease frequency
was set at 1/100,000. An autosomal dominant mode of gene (data not shown), the latter is excluded as a candi-
date gene for Albers-Scho¨nberg disease. To study CSF-inheritance was assumed, with a disease penetrance of
.60. Allele frequencies for the microsatellite markers 1 as a possible candidate gene, linkage analysis with
AMY2B was performed. A positive LOD score of 3.07were set at 1/n (n Å number of alleles).
was obtained at zero recombination (table 2). To con-
Mutation Analysis ﬁrm linkage of Albers-Scho¨nberg disease to the CSF-
1 region, nine additional polymorphic markers in andTo detect large rearrangements, DNA from patients
II-9, II-11, and II-22 was digested with several restriction around the CSF-1 gene were analyzed. First, the only
intragenic CSF-1 polymorphism (a KpnI RFLP) was ana-enzymes, separated by gelelectrophoresis, and trans-
ferred to Hybond N/ membranes by Southern blotting, lyzed but proved to be uninformative in this family.
Second, eight additional markers from the CSF-1 regionand hybridized with radiolabeled probes covering exons
2, 4, and 6 of the CSF-1 gene. To detect small mutations, on chromosome 1p21 were selected from the Ge´ne´thon
human linkage map (Gyapay et al. 1994; Dib et al.SSCP analysis was performed by use of HydroLinkMDE
gel (J.T. Baker) according to standard protocol. Intronic 1996). Two-point linkage analysis resulted in positive
LOD scores for all eight markers, and no recombinationprimers for the eight coding exons of the CSF-1 gene
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Figure 2 Pedigree of Danish family with Albers-Scho¨nberg disease. Male family members are represented by squares, and females are
represented by circles; blackened squares and circles denote affected individuals. Haplotypes for the chromosome 1 markers are shown below
the symbols. The haplotype consists of alleles from nine marker loci. The order, from telomere (top) to centromere (bottom), is D1S497,
D1S486, D1S495, AMY2B, D1SD248, D2S239, D1S2792, D1S221, and D1S457. The blackened bars represent the haplotype that cosegregates
with the disease. On the basis of the presence of the disease-associated haplotype, 19 individuals carry the disease gene, but only 13 show the
phenotype. This implies a penetrance of Ç68% in this family, which is slightly higher than the 56% previously estimated (Bollerslev 1989).
was found with markers D1S495, AMY2B, D1S248, the disease, mutation analysis was performed. Southern
blot, SSCP, and sequencing analysis of both the completeand D1S239 (table 2). Conclusive LOD scores ú3 were
obtained for two markers, D1S495 (Zmax Å 3.65) and coding sequence and the exon-intron boundaries of the
CSF-1 gene did not reveal any abnormality in the CSF-1AMY2B (Zmax Å 3.07) (table 2). Multipoint analysis
with markers D1S495, D1S248, D1S239, and D1S2792 gene, indicating that CSF-1 is not involved in the disease.
Additionally, reﬁned physical mapping of the CSF-1revealed Zmax Å 4.09 at loci D1S248/D1S239, conﬁrm-
ing linkage between this region and Albers-Scho¨nberg gene relative to the genetic candidate region was per-
formed. As shown in ﬁgure 3C, the CSF-1 gene is locateddisease. Key recombinants, represented in ﬁgure 3B, de-
lineate a candidate region of 8.5 cM between D1S486 within seven YACs that are positive for D1S221 but not
for the distal locus D1S2792. Since D1S2792 forms theand D1S2792. On the distal side the disease recombines
with D1S486 in individual II-17, whereas on the proxi- proximal boundary of the genetic candidate region, the
mapping of the CSF-1 gene proximal to this markermal side a recombination is detected both with D1S221
and D1S457 in individual II-16 and with D1S2792, implies that the CSF-1 gene is not located in the genetic
candidate region of the Albers-Scho¨nberg disease gene.D1S221, and D1S457 in individual III-14. The recombi-
national event between D1S495 and D1S239 in individ-
ual III-20 does not narrow the candidate region for the Discussion
disease, since individual III-20 is not clinically affected
and nonpenetrance is present in this pedigree, as illus- Animal models for genetic diseases can provide obvi-
ous candidate genes for the disease. In the mouse, natu-trated in individual II-7.
To test the possible involvement of the CSF-1 gene in rally occurring mutations in mitf and csf-1, as well as
/ 9a30$$au02 08-01-97 13:18:09 ajhga UC-AJHG
367Van Hul et al.: Albers-Scho¨nberg Disease on Chromosome 1p21
targeted disruption (knockout mutation) of c-src and c-
fos, result in autosomal recessive osteopetrosis (Yoshida
et al. 1990; Soriano et al. 1991; Wang et al. 1992; Hodg-
kinson et al. 1993). To test the involvement of the hu-
man homologues of these genes in Albers-Scho¨nberg dis-
ease, linkage analysis with polymorphisms located either
within these genes or in the ﬂanking regions was per-
formed. The signiﬁcance of the obtained results mostly
depends on both the accuracy of the available mapping
data of the human gene and the availability of closely
linked microsatellite markers. The current availability
of genetic maps saturated with highly polymorphic
markers and of detailed physical maps makes such can-
didate-gene strategy to identify disease genes a valuable
alternative for a random genome search.
After exclusion of SRC, FOS, and MITF as candidate
genes for Albers-Scho¨nberg disease, positive LOD scores
were found with markers around CSF-1 on chromosome
1p21. Key recombinants in family members II-17 and
III-14 indicated a candidate region of 8.5 cM between
D1S486 (distal side) and D1S2792 (proximal side). A
recombinational event between D1S495 and D1S239 in
individual III-20 did not narrow the candidate region,
since individual III-20 is not clinically affected and non-
penetrance is present in this pedigree (Bollerslev 1989),
as illustrated in individual II-7. On the basis of the pres-
ence of the disease-associated haplotype, 19 individuals
Figure 3 Delineation of the candidate region for the Albers-carry the disease gene, but only 13 show the phenotype.
Scho¨nberg disease gene. A, Idiogram of the proximal chromosome 1p
This suggests a penetrance of Ç68% in this family, region. B, Key recombinants in the family, which delineate the candi-
which is slightly higher than the 56% estimated by a date region for the Albers-Scho¨nberg disease gene. The blackened bars
represent the chromosomal regions that contain the disease gene, andprevious study (Bollerslev 1989).
the unblackened bars represent regions that do not contain the diseaseThe selection of the 1p21 region for linkage analysis
gene; the horizontal lines represent noninformative regions. The re-with Albers-Scho¨nberg disease was based on both the
combination, in individual II-17, between D1S486 and the Albers-
regional assignment of the CSF-1 gene to this region and Scho¨nberg disease gene localizes the disease gene proximal to D1S486.
the observation that the murine homologue of CSF-1 is The recombinational event with D1S221 in patient II-16 and that with
D1S2792 in patient III-14 indicate that the Albers-Scho¨nberg diseasemutated in the osteopetrotic op/op mouse model. To
gene must be located distal to D1S2792. C, Detailed physical mappingfurther analyze the possible involvement of the CSF-1
of the CSF-1 gene, by use of YACs from the chromosome 1p21 region.
The CSF-1 gene is not present in YAC 854C3, which is positive for
D1S2792, the proximal border of the genetic candidate region of the
Albers-Scho¨nberg gene. Furthermore, the CSF-1 gene is found in sevenTable 2
YACs that are located proximal to the candidate region; therefore, the
CSF-1 gene maps outside the candidate region of the Albers-Scho¨nbergPairwise LOD Scores between Albers-Scho¨nberg Disease and
disease gene.Markers from Chromosome 1p21
LOD SCORE AT RECOMBINATION FRACTION OF
gene, a mutation analysis in this gene was performed,MARKER .00 .01 .05 .10 .20 .30 .40
but this did not reveal a mutation. This makes it unlikely
D1S497 01.76 1.53 2.05 2.10 1.81 1.29 .62 that the CSF-1 gene harbors the disease-causing muta-
D1S486 02.09 1.20 1.75 1.83 1.59 1.11 .51 tion in this family. This was further conﬁrmed by the
D1S495 3.65 3.60 3.40 3.12 2.48 1.71 .81
physical mapping of the CSF-1 gene outside the candi-AMY2B 3.07 3.03 2.83 2.55 1.93 1.22 .47
date region. It is therefore likely that different pathologi-D1S248 1.88 1.85 1.74 1.59 1.25 .87 .45
D1S239 2.49 2.46 2.29 2.07 1.58 1.02 .42 cal mechanisms underly the osteopetrotic op/op mouse
D1S2792 02.00 1.32 1.79 1.78 1.41 .86 .29 model and Albers-Scho¨nberg disease. Since CSF-1 is a
D1S221 07.60 0.99 .27 .67 .82 .63 .29 hematopoietic growth factor playing a role in the matu-
D1S457 03.30 01.91 0.64 0.19 .09 .10 .01
ration of osteoclast and macrophages from progenitor
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Cruts M, Backhovens H, Wang S-Y, Van Gassen G, Theunscells (Kawasaki et al. 1985), impaired osteoclastic differ-
J, De Jonghe C, Wehnert A, et al (1995) Molecular geneticentiation can be expected after inactivation of CSF-1.
analysis of familial early-onset Alzheimer’s disease linked toIn the op/op osteopetrotic mouse, a mutation in CSF-1
chromosome 14q24.3. Hum Mol Genet 4:2363–2371(Yoshida et al. 1990) leads to a decreased number of
Dib C, Faure´ S, Fizames C, Samson E, Drouot N, Vignal A,abnormally small osteoclasts (Marks and Lane 1976).
Millasseau P, et al (1996) A comprehensive genetic map of
In Albers-Scho¨nberg disease, however, osteoclasts are the human genome based on 5,264 microsatellites. Nature
large and even increased in number (Bollerslev et al. 380:152–154
1993). Consequently, also on pathological grounds de- Dracopoli NC, Meisler MH (1990) Mapping the human amy-
creased activity of CSF-1 is not very likely to be the lase gene cluster on the proximal short arm of chromosome
mechanism involved in Albers-Scho¨nberg disease. 1 using a highly informative (CA)n repeat. Genomics 7:97–
102In conclusion, the Albers-Scho¨nberg gene has been
Gerritsen EJA, Vossen JM, Van Loo IHG, Hermans J, Helfrichlocated within an 8.5-cM candidate region on chromo-
MH, Griscelli C, Fischer A (1994) Autosomal recessive os-some 1p21. The mapping of this gene will facilitate its
teopetrosis: variability of ﬁndings at diagnosis and duringidentiﬁcation, which might result in new insights into
the natural course. Pediatrics 93:247–253the regulation of osteoclastic bone resorption and might
Gisselbrecht S, Sola B, Fichelson S, Bordereaux D, Tambourincontribute to an understanding of other clinical entities,
P, Mattei MG, Simon D, et al (1989) The murine M-CSF
such as osteoporosis, that are associated with abnormal gene is localized on chromosome 3. Blood 73:1742–1745
bone density. Gru¨nberg H (1935) A new sub-lethal color mutation in the
house mouse. Proc R Soc Lond B Biol Sci 118:321–342
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